Power Law company profile

Denali Therapeutics

Biotech & Life Sciences · South San Francisco, United States · Founded 2015 · IPO 2017 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$1.51B

Market cap · 2026

Investors

9 investors on Denali Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 6 investors entered at this stage

ARCH Venture Partners

Flagship Pioneering

Biomatics Capital Partners

F-Prime

Alaska Permanent Fund

Eight Roads Ventures

Series B+ 3 investors entered at this stage

Baillie Gifford

Foresite Capital

University Of Houston

Global footprint

Where Denali Therapeutics has talent and traffic

AI talent share

1.6% of workforce is AI talent
(9 of 568 staff)

Core AI20.35%

Other AI71.23%

Non-AI workforce55998.42%

Web traffic by country

35K monthly visits
across markets

🇺🇸 United States56.6%

🇯🇵 Japan15.7%

🏳️ Korea12%

🏳️ Republic of4.6%

🇨🇭 Switzerland3.1%

Top 5 markets shown

Patent intelligence

$92M patent portfolio · 111 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$92M

6.1% of market cap · 22× smaller than top peer Ablynx ($2B)

111 active patent families

Where Denali Therapeutics innovates Molecular biologyProdrugStereoisomerismCell biologyPharmaceutical medicine

Tracks the peer median across all five Patsnap quality dimensions.

Quality vs same-sector peers

Denali Therapeutics on the five Patsnap quality dimensions

Denali Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Denali Therapeutics concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Denali Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Denali Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo